PT982305E - Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem - Google Patents

Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem

Info

Publication number
PT982305E
PT982305E PT99402092T PT99402092T PT982305E PT 982305 E PT982305 E PT 982305E PT 99402092 T PT99402092 T PT 99402092T PT 99402092 T PT99402092 T PT 99402092T PT 982305 E PT982305 E PT 982305E
Authority
PT
Portugal
Prior art keywords
compounds
preparation
pharmaceutically acceptable
relates
present
Prior art date
Application number
PT99402092T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Mark Millan
Adrian Newman-Tancredi
Bertrand Goument
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PT982305E publication Critical patent/PT982305E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PT99402092T 1998-08-21 1999-08-20 Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem PT982305E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810601A FR2782515B1 (fr) 1998-08-21 1998-08-21 NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (1)

Publication Number Publication Date
PT982305E true PT982305E (pt) 2002-07-31

Family

ID=9529811

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99402092T PT982305E (pt) 1998-08-21 1999-08-20 Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem

Country Status (19)

Country Link
US (1) US6153625A (pt)
EP (1) EP0982305B1 (pt)
JP (1) JP2000072748A (pt)
CN (1) CN1128144C (pt)
AT (1) ATE214064T1 (pt)
AU (1) AU747494B2 (pt)
BR (1) BR9903867A (pt)
CA (1) CA2280596A1 (pt)
DE (1) DE69900961T2 (pt)
DK (1) DK0982305T3 (pt)
ES (1) ES2172294T3 (pt)
FR (1) FR2782515B1 (pt)
HK (1) HK1026212A1 (pt)
HU (1) HUP9902784A3 (pt)
NO (1) NO317516B1 (pt)
NZ (1) NZ337362A (pt)
PL (1) PL194852B1 (pt)
PT (1) PT982305E (pt)
ZA (1) ZA995321B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030070916A (ko) * 2001-01-16 2003-09-02 아스트라제네카 아베 치료용 크로몬 화합물
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
SE0103647D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chromone compounds
KR20080079341A (ko) * 2001-01-16 2008-08-29 아스트라제네카 아베 치료용 헤테로시클릭 화합물
CA2434015A1 (en) * 2001-01-16 2002-07-18 Astrazeneca Ab Therapeutic chroman compounds
DE10142662B4 (de) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142661B4 (de) 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
DE69900961T2 (de) 2002-11-07
DK0982305T3 (da) 2002-06-24
NO317516B1 (no) 2004-11-08
CA2280596A1 (fr) 2000-02-21
HUP9902784A2 (hu) 2000-12-28
CN1128144C (zh) 2003-11-19
CN1250051A (zh) 2000-04-12
NZ337362A (en) 2000-04-28
ATE214064T1 (de) 2002-03-15
EP0982305A1 (fr) 2000-03-01
NO994041D0 (no) 1999-08-20
AU4463799A (en) 2000-03-09
HUP9902784A3 (en) 2001-03-28
FR2782515B1 (fr) 2000-09-22
DE69900961D1 (de) 2002-04-11
EP0982305B1 (fr) 2002-03-06
ES2172294T3 (es) 2002-09-16
NO994041L (no) 2000-02-22
FR2782515A1 (fr) 2000-02-25
ZA995321B (en) 2000-02-22
AU747494B2 (en) 2002-05-16
BR9903867A (pt) 2000-09-05
HU9902784D0 (en) 1999-10-28
PL335012A1 (en) 2000-02-28
PL194852B1 (pl) 2007-07-31
JP2000072748A (ja) 2000-03-07
US6153625A (en) 2000-11-28
HK1026212A1 (en) 2000-12-08

Similar Documents

Publication Publication Date Title
HUP0400250A2 (hu) 5-HT6 és/vagy 5-HT7 szerotonin receptorok ligandumaként alkalmazott 5-halogén-triptamin-származékok, előállításuk és alkalmazásuk gyógyszerkészítmények előállítására
HUP0101146A2 (hu) Foszfolipáz enzim inhibitor hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyászati készítmények
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
BR9812046A (pt) Compostos, processos para a preperação do composto e para tratar um paciente humano ou animal, composição farmacêutica, e, uso de um composto
SE0104334D0 (sv) Therapeutic agents
ATE52498T1 (de) Amidderivate.
BR0015195A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma condição associada com a transmissão reduzida de nicotina para o tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para o tratamento ou profilaxia de doenças ou condições humanas
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
PT982305E (pt) Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem
EE200200591A (et) Püridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks ühenditeks
DK1109560T3 (da) Som AICARFT-inhibitorer anvendelige forbindelser
HUP0300295A2 (hu) Helyettesített benzamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP9902199A1 (hu) Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények
HUT59124A (en) Process for producing 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
ITMI20042475A1 (it) Uso di derivati tiazolidinonici come agenti terapeutici
ES527353A0 (es) Procedimiento de preparacion de nuevos derivados de la nitrosourea
EA200101109A1 (ru) Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана
SE9900190D0 (sv) New compounds
NO20023381D0 (no) Indolderivater som MCP-1-reseptoragonister
DK601783D0 (da) Resorcinderivater
ES2192827T3 (es) Derivados de 8h-(2,3-b)-pirrolicin-8-ona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE0100344D0 (sv) New Use
HUP0100750A2 (hu) Új 6-szulfamoil-3-kinolilfoszfonsav származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények